IL11 and neoplasm: Thus, as the enIL‐11 cytokine binds to human IL‐11R with a tighter affinity as compared with mIL‐11R it is possible that its therapeutic efficacy in mouse tumor models will be underestimated due to less effective inhibition of endogenous mouse IL‐11 protein.